FindTrial
Sign In

FAR for mortality in kidney failure patient

FIBRINOGEN TO ALBUMIN RATIO AS PREDICTOR OF IN HOSPITAL MORTALITY IN CRITICALLY ILL PATIENT WITH SEPSIS & ACUTE KIDNEY INJURY ADMITTED IN INTENSIVE CARE UNIT - FAR

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/10/058868
Enrollment
64
Registered
2023-10-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N178- Other acute kidney failure

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Dr SUJEET RAI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients = 18 years of age Hospitalized in the ICU at first admission for more than 2 days Patients give consent for study

Exclusion criteria

Exclusion criteria: age 65years patient received FFP, CPP, Albumin and any blood product before investigation patient with chronic liver disease Refused to give consent for study

Design outcomes

Primary

MeasureTime frame
To estimate difference in mortality between patients with low & high Fibrinogen-to albumin ratio (FAR) admitted with sepsis & having Acute kidney injury in intensive care unit Timepoint: blood sample within 24 hour of diagnosis till patient outcome—

Secondary

MeasureTime frame
To measure correlation between SOFA score & FAR. To measure correlation between APACHE-2 and FAR. Timepoint: blood sample within 24 hour of diagnosis till patient outcome—

Countries

India

Contacts

Public ContactDr Anil Kumar

Dr Ram Manohar Lohia Institute of Medical Sciences Lucknow

drsujeetrai@gmail.com9161758940

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026